Breaking News
Investing Pro 0
NEW! Get Actionable Insights with InvestingPro+ Try 7 Days Free

Sanofi SA (SASY)

Create Alert
Create Alert
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile






Delivery Method


Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
98.28 +0.76    +0.78%
13:30:20 - Real-time Data. Currency in EUR ( Disclaimer )
  • Volume: 358,127
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 97.83 - 98.76
Type:  Equity
Market:  France
ISIN:  FR0000120578 
Sanofi 98.28 +0.76 +0.78%
  • General    
  • Chart    
  • News & Analysis    
  • Financials    
  • Technical    
  • Forum    
  • InvestingPro
InvestingPro Advanced Income Statement
Period Ending: 2022
Total Revenue 10053 21244 10829 17931
Revenue 10053 21244 10829 17931
Other Revenue, Total - - - -
Cost of Revenue, Total 2880 6714 3238 5541
Gross Profit 7173 14530 7591 12390
Total Operating Expenses 7656 16731 7787 14318
Selling/General/Admin. Expenses, Total 2379 5025 2267 4530
Research & Development 1489 3029 1443 2663
Depreciation / Amortization 449 805 385 775
Interest Expense (Income) - Net Operating - - - -
Unusual Expense (Income) 198 512 170 505
Other Operating Expenses, Total 261 646 284 304
Operating Income 2397 4513 3042 3613
Interest Income (Expense), Net Non-Operating -78 -153 -85 -155
Gain (Loss) on Sale of Assets - - - -
Other, Net - -14 - -6
Net Income Before Taxes 2319 4346 2957 3452
Provision for Income Taxes 332 876 609 682
Net Income After Taxes 1987 3470 2348 2770
Minority Interest -8 -36 -26 -20
Equity In Affiliates 30 13 -5 26
U.S GAAP Adjustment - - - -
Net Income Before Extraordinary Items 2009 3447 2317 2776
Total Extraordinary Items - - - -
Net Income 2009 3447 2317 2776
Total Adjustments to Net Income - - - -
Income Available to Common Excluding Extraordinary Items 2009 3447 2317 2776
Dilution Adjustment - - - -1.12
Diluted Net Income 2009 3447 2317 2776
Diluted Weighted Average Shares 1249.2 1260.2 1254.5 1255.6
Diluted EPS Excluding Extraordinary Items 1.61 2.74 1.85 2.21
DPS - Common Stock Primary Issue - 3.31 - -
Diluted Normalized EPS 1.74 3.06 1.95 2.53
* In Millions of EUR (except for per share items)
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at’s discretion.

SASY Comments

Write your thoughts about Sanofi SA
Are you sure you want to delete this chart?
Post also to:
Replace the attached chart with a new chart ?
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Greg Greg
Greg Greg Dec 11, 2020 9:36
Saved. See Saved Items.
This comment has already been saved in your Saved Items
there is no future for it
Are you sure you want to delete this chart?
Replace the attached chart with a new chart ?
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Our Apps
© 2007-2022 Fusion Media Limited. All Rights Reserved.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
  • Sign up for FREE and get:
  • Real-Time Alerts
  • Advanced Portfolio Features
  • Personalized Charts
  • Fully-Synced App
Continue with Google
Sign up with Email